Cargando…
Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity
Parkinson's disease (PD) is a common neurodegenerative disorder of unknown pathogenesis characterized by the loss of nigrostriatal dopaminergic neurons. Oxidative stress, microglial activation and inflammatory responses seem to contribute to the pathogenesis. The receptor for advanced glycation...
Autores principales: | Teismann, Peter, Sathe, Kinnari, Bierhaus, Angelika, Leng, Lin, Martin, Heather L., Bucala, Richard, Weigle, Bernd, Nawroth, Peter P., Schulz, Jörg B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712169/ https://www.ncbi.nlm.nih.gov/pubmed/22227007 http://dx.doi.org/10.1016/j.neurobiolaging.2011.12.006 |
Ejemplares similares
-
Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice
por: McVicar, Carmel M., et al.
Publicado: (2015) -
S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway
por: Sathe, Kinnari, et al.
Publicado: (2012) -
The role of receptor for advanced glycation endproducts (RAGE) in infection
por: van Zoelen , Marieke AD, et al.
Publicado: (2011) -
The Role of Receptor for Advanced Glycation Endproducts (RAGE) in Infection
por: van Zoelen, M. A. D., et al.
Publicado: (2011) -
Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
por: Drake, Lindsey R., et al.
Publicado: (2020)